Passage Bio (PASG) news
Recent news
CPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 2d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 2d agoPassage Bio - Dr. Smith to lead combined company, Matthew Patterson to chair board, Peter Colabuono to join board
AInvest Wire · Jun 24, 2026Passage Bio - shareholders to own 7%, Remix stockholders 93% of combined company
Passage Bio, Inc. (NASDAQ: PASG) has announced a 1-for-20 reverse stock split, effective July 14, 2025, to regain compliance with minimum bid price requirement . The move was approved by stockholders at the company’s 2025 annual meeting . The reverse stock split reduces outstanding shares from…
AInvest Wire · Jun 24, 2026Passage Bio - combined company to operate as Remix Therapeutics, trade as RMTX on Nasdaq
AInvest Wire · Jun 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.